ID GMPPA_HUMAN Reviewed; 420 AA. AC Q96IJ6; A6NJ74; A8K3Q6; B3KMT4; Q53GI0; Q9NWC3; Q9Y5P5; DT 08-APR-2008, integrated into UniProtKB/Swiss-Prot. DT 01-DEC-2001, sequence version 1. DT 27-MAR-2024, entry version 171. DE RecName: Full=Mannose-1-phosphate guanyltransferase alpha; DE AltName: Full=GDP-mannose pyrophosphorylase A; DE Short=GMPP-alpha; DE AltName: Full=GTP-mannose-1-phosphate guanylyltransferase alpha; GN Name=GMPPA; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Matthijs G., Schollen E., Dierickx D.; RT "Human homolog of GDP-mannose pyrophosphorylase."; RL Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases. RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Embryo; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RC TISSUE=Kidney; RA Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y., RA Tanaka A., Yokoyama S.; RL Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=15815621; DOI=10.1038/nature03466; RA Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P., RA Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C., RA Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L., RA Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A., RA Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J., RA Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M., RA Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T., RA Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S., RA Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K., RA McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C., RA Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S., RA Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C., RA Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M., RA Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C., RA Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J., RA Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E., RA Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X., RA Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M., RA Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C., RA Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S., RA Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H., RA Wilson R.K.; RT "Generation and annotation of the DNA sequences of human chromosomes 2 and RT 4."; RL Nature 434:724-731(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Lymph; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [8] RP VARIANTS AAMR ASP-182; MET-334; PRO-334; PRO-390 AND THR-401, FUNCTION, RP SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY. RX PubMed=24035193; DOI=10.1016/j.ajhg.2013.08.002; RA Koehler K., Malik M., Mahmood S., Giesselmann S., Beetz C., Hennings J.C., RA Huebner A.K., Grahn A., Reunert J., Nurnberg G., Thiele H., Altmuller J., RA Nurnberg P., Mumtaz R., Babovic-Vuksanovic D., Basel-Vanagaite L., RA Borck G., Bramswig J., Muhlenberg R., Sarda P., Sikiric A., RA Anyane-Yeboa K., Zeharia A., Ahmad A., Coubes C., Wada Y., Marquardt T., RA Vanderschaeghe D., Van Schaftingen E., Kurth I., Huebner A., Hubner C.A.; RT "Mutations in GMPPA cause a glycosylation disorder characterized by RT intellectual disability and autonomic dysfunction."; RL Am. J. Hum. Genet. 93:727-734(2013). CC -!- FUNCTION: May serve as a regulatory subunit and allow allosteric CC feedback inhibition of GMPPB by GDP-mannose. CC {ECO:0000269|PubMed:24035193}. CC -!- SUBUNIT: Associates with GMPPB. {ECO:0000250}. CC -!- INTERACTION: CC Q96IJ6; P46379-2: BAG6; NbExp=3; IntAct=EBI-750953, EBI-10988864; CC Q96IJ6; P35070: BTC; NbExp=6; IntAct=EBI-750953, EBI-6590057; CC Q96IJ6; P02741: CRP; NbExp=3; IntAct=EBI-750953, EBI-1395983; CC Q96IJ6; Q96GG9: DCUN1D1; NbExp=3; IntAct=EBI-750953, EBI-740086; CC Q96IJ6; O14645: DNALI1; NbExp=3; IntAct=EBI-750953, EBI-395638; CC Q96IJ6; Q01658: DR1; NbExp=3; IntAct=EBI-750953, EBI-750300; CC Q96IJ6; Q9Y5P6: GMPPB; NbExp=8; IntAct=EBI-750953, EBI-750945; CC Q96IJ6; Q92917: GPKOW; NbExp=3; IntAct=EBI-750953, EBI-746309; CC Q96IJ6; Q9Y5Q9: GTF3C3; NbExp=3; IntAct=EBI-750953, EBI-1054873; CC Q96IJ6; O14901: KLF11; NbExp=3; IntAct=EBI-750953, EBI-948266; CC Q96IJ6; A0A0S2Z4D7: NCK1; NbExp=3; IntAct=EBI-750953, EBI-16429340; CC Q96IJ6; Q13148: TARDBP; NbExp=6; IntAct=EBI-750953, EBI-372899; CC Q96IJ6; A0A0S2Z6P0: ZNF688; NbExp=3; IntAct=EBI-750953, EBI-16429989; CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:24035193}. CC Note=Myc-tagged GMPPA shows a diffuse cytoplasmic and nuclear pattern CC in transfected COS-7 cells. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q96IJ6-1; Sequence=Displayed; CC Name=2; CC IsoId=Q96IJ6-2; Sequence=VSP_032741; CC -!- TISSUE SPECIFICITY: Expressed in fibroblasts (at protein level). CC {ECO:0000269|PubMed:24035193}. CC -!- DISEASE: Alacrima, achalasia, and impaired intellectual development CC syndrome (AAMR) [MIM:615510]: An autosomal recessive disorder CC characterized by onset of alacrima, achalasia, and intellectual CC disability at birth or in early infancy. More variable features include CC hypotonia, gait abnormalities, anisocoria, and visual or hearing CC deficits. The disorder shows similarity to the triple A syndrome, but CC patients with AAMR do not have adrenal insufficiency. CC {ECO:0000269|PubMed:24035193}. Note=The disease is caused by variants CC affecting the gene represented in this entry. CC -!- SIMILARITY: Belongs to the transferase hexapeptide repeat family. CC {ECO:0000305}. CC -!- CAUTION: GMPPA is a close homolog of GMPPB, that has been shown to CC catalyze the formation of GDP-mannose, an essential precursor of glycan CC moieties of glycoproteins and glycolipids. However, lymphocytes from CC AAMR patients, that exhibit very low GMPPA protein levels, have CC unchanged GDP-mannose pyrophosphorylase activity and higher GDP-mannose CC levels than those from healthy controls. Affected individuals and CC control subjects show similar N-glycosylation profiles, both for CC transferrin glycosylation and for N-glycans derived from either total CC serum protein or immunoglobulin G. These observations led to the CC hypothesis that GMPPA might serve as a regulatory subunit and allow CC allosteric feedback inhibition of GMPPB by GDP-mannose. Alignment of CC GMPPAs and GMPPBs from various species shows that GMPPAs are CC characterized by a 2 amino acid-insertion (residues 11-12) in a highly CC conserved motif that borders the catalytic pocket and binds the CC nucleotide substrate in homologous enzymes. This insertion might CC inactivate the ancestral catalytic site, converting it to an allosteric CC site (PubMed:24035193). {ECO:0000305|PubMed:24035193}. CC -!- SEQUENCE CAUTION: CC Sequence=AAD38517.1; Type=Frameshift; Evidence={ECO:0000305}; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF135422; AAD38517.1; ALT_FRAME; mRNA. DR EMBL; AK000999; BAA91460.1; -; mRNA. DR EMBL; AK022578; BAG51096.1; -; mRNA. DR EMBL; AK290671; BAF83360.1; -; mRNA. DR EMBL; AK222951; BAD96671.1; -; mRNA. DR EMBL; AC053503; AAY15053.1; -; Genomic_DNA. DR EMBL; CH471063; EAW70755.1; -; Genomic_DNA. DR EMBL; CH471063; EAW70759.1; -; Genomic_DNA. DR EMBL; BC007456; AAH07456.1; -; mRNA. DR CCDS; CCDS2441.1; -. [Q96IJ6-1] DR RefSeq; NP_037467.2; NM_013335.3. [Q96IJ6-1] DR RefSeq; NP_995319.1; NM_205847.2. [Q96IJ6-1] DR RefSeq; XP_005246543.1; XM_005246486.3. DR RefSeq; XP_016859398.1; XM_017003909.1. DR RefSeq; XP_016859399.1; XM_017003910.1. DR RefSeq; XP_016859400.1; XM_017003911.1. DR PDB; 7D72; EM; 3.40 A; A/B/C/D=1-420. DR PDB; 7D73; EM; 3.00 A; A/B/C/D=1-420. DR PDB; 7D74; EM; 3.10 A; A/B/C/D=1-420. DR PDBsum; 7D72; -. DR PDBsum; 7D73; -. DR PDBsum; 7D74; -. DR AlphaFoldDB; Q96IJ6; -. DR EMDB; EMD-30599; -. DR EMDB; EMD-30600; -. DR EMDB; EMD-30601; -. DR SMR; Q96IJ6; -. DR BioGRID; 118967; 52. DR IntAct; Q96IJ6; 24. DR MINT; Q96IJ6; -. DR STRING; 9606.ENSP00000350949; -. DR GlyGen; Q96IJ6; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; Q96IJ6; -. DR PhosphoSitePlus; Q96IJ6; -. DR BioMuta; GMPPA; -. DR DMDM; 74732065; -. DR EPD; Q96IJ6; -. DR jPOST; Q96IJ6; -. DR MassIVE; Q96IJ6; -. DR MaxQB; Q96IJ6; -. DR PaxDb; 9606-ENSP00000350949; -. DR PeptideAtlas; Q96IJ6; -. DR ProteomicsDB; 76833; -. [Q96IJ6-1] DR ProteomicsDB; 76834; -. [Q96IJ6-2] DR Pumba; Q96IJ6; -. DR Antibodypedia; 34335; 140 antibodies from 24 providers. DR DNASU; 29926; -. DR Ensembl; ENST00000313597.10; ENSP00000315925.6; ENSG00000144591.20. [Q96IJ6-1] DR Ensembl; ENST00000341142.8; ENSP00000340760.3; ENSG00000144591.20. [Q96IJ6-1] DR Ensembl; ENST00000358215.8; ENSP00000350949.3; ENSG00000144591.20. [Q96IJ6-1] DR Ensembl; ENST00000373908.5; ENSP00000363016.1; ENSG00000144591.20. [Q96IJ6-1] DR Ensembl; ENST00000373917.7; ENSP00000363027.3; ENSG00000144591.20. [Q96IJ6-2] DR Ensembl; ENST00000622191.2; ENSP00000478700.2; ENSG00000144591.20. [Q96IJ6-1] DR Ensembl; ENST00000683946.1; ENSP00000506941.1; ENSG00000144591.20. [Q96IJ6-1] DR GeneID; 29926; -. DR KEGG; hsa:29926; -. DR MANE-Select; ENST00000313597.10; ENSP00000315925.6; NM_013335.4; NP_037467.2. DR UCSC; uc002vlr.4; human. [Q96IJ6-1] DR AGR; HGNC:22923; -. DR CTD; 29926; -. DR DisGeNET; 29926; -. DR GeneCards; GMPPA; -. DR HGNC; HGNC:22923; GMPPA. DR HPA; ENSG00000144591; Low tissue specificity. DR MalaCards; GMPPA; -. DR MIM; 615495; gene. DR MIM; 615510; phenotype. DR neXtProt; NX_Q96IJ6; -. DR OpenTargets; ENSG00000144591; -. DR Orphanet; 869; Triple A syndrome. DR PharmGKB; PA134925506; -. DR VEuPathDB; HostDB:ENSG00000144591; -. DR eggNOG; KOG1460; Eukaryota. DR GeneTree; ENSGT00940000157018; -. DR HOGENOM; CLU_029499_3_0_1; -. DR InParanoid; Q96IJ6; -. DR OMA; MPVPNWW; -. DR OrthoDB; 5486038at2759; -. DR PhylomeDB; Q96IJ6; -. DR TreeFam; TF300832; -. DR PathwayCommons; Q96IJ6; -. DR Reactome; R-HSA-446205; Synthesis of GDP-mannose. DR SignaLink; Q96IJ6; -. DR BioGRID-ORCS; 29926; 11 hits in 1162 CRISPR screens. DR ChiTaRS; GMPPA; human. DR GenomeRNAi; 29926; -. DR Pharos; Q96IJ6; Tbio. DR PRO; PR:Q96IJ6; -. DR Proteomes; UP000005640; Chromosome 2. DR RNAct; Q96IJ6; Protein. DR Bgee; ENSG00000144591; Expressed in body of pancreas and 170 other cell types or tissues. DR ExpressionAtlas; Q96IJ6; baseline and differential. DR GO; GO:0005737; C:cytoplasm; IBA:GO_Central. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0016740; F:transferase activity; IEA:InterPro. DR GO; GO:0009058; P:biosynthetic process; IEA:InterPro. DR CDD; cd06428; M1P_guanylylT_A_like_N; 1. DR Gene3D; 2.160.10.10; Hexapeptide repeat proteins; 1. DR InterPro; IPR001451; Hexapep. DR InterPro; IPR018357; Hexapep_transf_CS. DR InterPro; IPR005835; NTP_transferase_dom. DR InterPro; IPR029044; Nucleotide-diphossugar_trans. DR PANTHER; PTHR22572:SF104; MANNOSE-1-PHOSPHATE GUANYLTRANSFERASE ALPHA; 1. DR PANTHER; PTHR22572; SUGAR-1-PHOSPHATE GUANYL TRANSFERASE; 1. DR Pfam; PF00132; Hexapep; 1. DR Pfam; PF00483; NTP_transferase; 1. DR SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1. DR PROSITE; PS00101; HEXAPEP_TRANSFERASES; 1. DR Genevisible; Q96IJ6; HS. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Cytoplasm; Disease variant; KW Intellectual disability; Reference proteome. FT CHAIN 1..420 FT /note="Mannose-1-phosphate guanyltransferase alpha" FT /id="PRO_0000327872" FT VAR_SEQ 285 FT /note="G -> GTQPAPIPNLWLPPQPSEPGFLTSSPELKPQSLPLPDQIRFGIFAPR FT ASLLLLG (in isoform 2)" FT /evidence="ECO:0000305" FT /id="VSP_032741" FT VARIANT 21 FT /note="S -> F (in dbSNP:rs34218609)" FT /id="VAR_042434" FT VARIANT 156 FT /note="V -> A (in dbSNP:rs13396066)" FT /id="VAR_042435" FT VARIANT 182 FT /note="G -> D (in AAMR; drastically reduced protein FT expression; dbSNP:rs397518462)" FT /evidence="ECO:0000269|PubMed:24035193" FT /id="VAR_070203" FT VARIANT 334 FT /note="T -> M (in AAMR; dbSNP:rs774778439)" FT /evidence="ECO:0000269|PubMed:24035193" FT /id="VAR_070204" FT VARIANT 334 FT /note="T -> P (in AAMR; drastically reduced protein FT expression; dbSNP:rs397518461)" FT /evidence="ECO:0000269|PubMed:24035193" FT /id="VAR_070205" FT VARIANT 390 FT /note="R -> P (in AAMR; drastically reduced protein FT expression; dbSNP:rs1467274040)" FT /evidence="ECO:0000269|PubMed:24035193" FT /id="VAR_070206" FT VARIANT 401 FT /note="N -> T (in AAMR; drastically reduced protein FT expression)" FT /evidence="ECO:0000269|PubMed:24035193" FT /id="VAR_070207" FT CONFLICT 57 FT /note="G -> C (in Ref. 3; BAD96671)" FT /evidence="ECO:0000305" FT CONFLICT 67 FT /note="Q -> H (in Ref. 2; BAF83360)" FT /evidence="ECO:0000305" FT CONFLICT 118 FT /note="C -> Y (in Ref. 2; BAA91460)" FT /evidence="ECO:0000305" FT CONFLICT 339 FT /note="S -> C (in Ref. 1; AAD38517)" FT /evidence="ECO:0000305" FT STRAND 2..7 FT /evidence="ECO:0007829|PDB:7D73" FT TURN 11..14 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 15..17 FT /evidence="ECO:0007829|PDB:7D74" FT STRAND 22..24 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 26..28 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 29..31 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 36..46 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 50..57 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 63..76 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 80..84 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 90..97 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 99..102 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 108..119 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 123..133 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 136..143 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 148..151 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 154..158 FT /evidence="ECO:0007829|PDB:7D73" FT TURN 159..162 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 163..170 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 177..186 FT /evidence="ECO:0007829|PDB:7D73" FT TURN 188..190 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 191..201 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 222..225 FT /evidence="ECO:0007829|PDB:7D73" FT TURN 226..229 FT /evidence="ECO:0007829|PDB:7D73" FT TURN 231..234 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 236..240 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 245..247 FT /evidence="ECO:0007829|PDB:7D73" FT HELIX 251..268 FT /evidence="ECO:0007829|PDB:7D73" FT TURN 270..272 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 285..289 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 305..307 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 318..321 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 335..341 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 352..354 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 362..366 FT /evidence="ECO:0007829|PDB:7D72" FT STRAND 374..380 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 385..387 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 398..401 FT /evidence="ECO:0007829|PDB:7D73" FT STRAND 414..416 FT /evidence="ECO:0007829|PDB:7D73" SQ SEQUENCE 420 AA; 46291 MW; 741B77ABA198D4BC CRC64; MLKAVILIGG PQKGTRFRPL SFEVPKPLFP VAGVPMIQHH IEACAQVPGM QEILLIGFYQ PDEPLTQFLE AAQQEFNLPV RYLQEFAPLG TGGGLYHFRD QILAGSPEAF FVLNADVCSD FPLSAMLEAH RRQRHPFLLL GTTANRTQSL NYGCIVENPQ THEVLHYVEK PSTFISDIIN CGIYLFSPEA LKPLRDVFQR NQQDGQLEDS PGLWPGAGTI RLEQDVFSAL AGQGQIYVHL TDGIWSQIKS AGSALYASRL YLSRYQDTHP ERLAKHTPGG PWIRGNVYIH PTAKVAPSAV LGPNVSIGKG VTVGEGVRLR ESIVLHGATL QEHTCVLHSI VGWGSTVGRW ARVEGTPSDP NPNDPRARMD SESLFKDGKL LPAITILGCR VRIPAEVLIL NSIVLPHKEL SRSFTNQIIL //